LYVE1 and Osteopenia: Taken together, HAR effectively inhibited the incidence and symptoms in CIA-induced RA mice and effectively suppressed bone loss caused by chronic autoimmune diseases, thereby effectively defending against inflammatory arthritis and bone diseases such as osteopenia and osteoporosis.